| 0 |
PROTEIN S INCREASED |
1 |
0.0357 |
| 1 |
CRYOTHERAPY |
1 |
0.0135 |
| 2 |
MEAN PLATELET VOLUME ABNORMAL |
1 |
0.0125 |
| 3 |
RENAL CELL CARCINOMA RECURRENT |
1 |
0.0079 |
| 4 |
TESTICULAR FAILURE |
1 |
0.0073 |
| 5 |
RED CELL DISTRIBUTION WIDTH ABNORMAL |
1 |
0.0053 |
| 6 |
MYOCARDITIS-MYOSITIS-MYASTHENIA GRAVIS OVERLAP SYNDROME |
1 |
0.0044 |
| 7 |
HYDROURETER |
1 |
0.0026 |
| 8 |
PRODUCT ADMINISTERED BY WRONG PERSON |
1 |
0.0026 |
| 9 |
BLOOD CREATINE ABNORMAL |
1 |
0.0021 |
| 10 |
CORTISOL INCREASED |
1 |
0.0016 |
| 11 |
EOSINOPHIL COUNT ABNORMAL |
1 |
0.0013 |
| 12 |
TRACHEITIS |
1 |
0.0013 |
| 13 |
CREATINE KINASE INCREASED |
1 |
0.0013 |
| 14 |
BLADDER CATHETERISATION |
1 |
0.0010 |
| 15 |
LYMPHOCYTE COUNT ABNORMAL |
1 |
0.0009 |
| 16 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
1 |
0.0009 |
| 17 |
HAEMATOCRIT ABNORMAL |
1 |
0.0008 |
| 18 |
INTERCEPTED PRODUCT SELECTION ERROR |
1 |
0.0008 |
| 19 |
RED BLOOD CELL COUNT ABNORMAL |
1 |
0.0007 |
| 20 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 21 |
IMMUNE-MEDIATED ADVERSE REACTION |
1 |
0.0007 |
| 22 |
OXYGEN THERAPY |
1 |
0.0006 |
| 23 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 24 |
THERAPY CHANGE |
4 |
0.0004 |
| 25 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 26 |
ORAL FUNGAL INFECTION |
1 |
0.0004 |
| 27 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 28 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 29 |
GRANULOMA |
1 |
0.0003 |
| 30 |
HYPERTRANSAMINASAEMIA |
2 |
0.0003 |
| 31 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 32 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 33 |
MUSCLE FATIGUE |
1 |
0.0002 |
| 34 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 35 |
ENERGY INCREASED |
1 |
0.0002 |
| 36 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 37 |
GENERALISED OEDEMA |
2 |
0.0002 |
| 38 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 39 |
ATRIOVENTRICULAR BLOCK COMPLETE |
1 |
0.0001 |
| 40 |
BRONCHIECTASIS |
1 |
0.0001 |
| 41 |
HYPERTHYROIDISM |
2 |
0.0001 |
| 42 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 43 |
INTERCEPTED PRODUCT ADMINISTRATION ERROR |
1 |
0.0001 |
| 44 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 45 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 46 |
MYOSITIS |
1 |
0.0001 |
| 47 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 48 |
EYELID PTOSIS |
1 |
0.0001 |
| 49 |
DRY THROAT |
1 |
0.0001 |
| 50 |
MYOCARDITIS |
1 |
0.0001 |
| 51 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 52 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 53 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 54 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 55 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 56 |
GAIT INABILITY |
2 |
0.0001 |
| 57 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 58 |
HYPERGLYCAEMIA |
2 |
0.0001 |
| 59 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 60 |
BLOOD GLUCOSE ABNORMAL |
1 |
0.0001 |
| 61 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 62 |
RETCHING |
1 |
0.0000 |
| 63 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 64 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 65 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 66 |
ENCEPHALOPATHY |
1 |
0.0000 |
| 67 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 68 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 69 |
EAR INFECTION |
1 |
0.0000 |
| 70 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 71 |
SKIN LESION |
1 |
0.0000 |
| 72 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 73 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 74 |
HERPES ZOSTER |
2 |
0.0000 |
| 75 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 76 |
INJECTION SITE RASH |
1 |
0.0000 |
| 77 |
INJECTION SITE ERYTHEMA |
4 |
0.0000 |
| 78 |
SWOLLEN TONGUE |
1 |
0.0000 |
| 79 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 80 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 81 |
DYSARTHRIA |
1 |
0.0000 |
| 82 |
DRY MOUTH |
2 |
0.0000 |
| 83 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 84 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
4 |
0.0000 |
| 85 |
DYSPHAGIA |
2 |
0.0000 |
| 86 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 87 |
DRY EYE |
1 |
0.0000 |
| 88 |
CELLULITIS |
1 |
0.0000 |
| 89 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 90 |
BRADYCARDIA |
1 |
0.0000 |
| 91 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 92 |
HYPONATRAEMIA |
1 |
0.0000 |
| 93 |
FLATULENCE |
1 |
0.0000 |
| 94 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 95 |
DYSPHONIA |
1 |
0.0000 |
| 96 |
NO ADVERSE EVENT |
3 |
0.0000 |
| 97 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 98 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 99 |
AMNESIA |
1 |
0.0000 |
| 100 |
DYSGEUSIA |
1 |
0.0000 |
| 101 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 102 |
ARTHRITIS |
1 |
0.0000 |
| 103 |
MYALGIA |
2 |
0.0000 |
| 104 |
BALANCE DISORDER |
1 |
0.0000 |
| 105 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 106 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 107 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 108 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 109 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 110 |
CHILLS |
1 |
0.0000 |
| 111 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 112 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 113 |
PRURITUS |
3 |
0.0000 |
| 114 |
PSORIASIS |
1 |
0.0000 |
| 115 |
RENAL FAILURE |
1 |
0.0000 |
| 116 |
DEHYDRATION |
1 |
0.0000 |
| 117 |
ARTHRALGIA |
3 |
0.0000 |
| 118 |
COUGH |
2 |
0.0000 |
| 119 |
RASH |
3 |
0.0000 |
| 120 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 121 |
HYPOAESTHESIA |
1 |
0.0000 |
| 122 |
HOSPITALISATION |
1 |
0.0000 |
| 123 |
FATIGUE |
5 |
0.0000 |
| 124 |
PARAESTHESIA |
1 |
0.0000 |
| 125 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 126 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 127 |
CHEST PAIN |
1 |
0.0000 |
| 128 |
ASTHENIA |
2 |
0.0000 |
| 129 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 130 |
PAIN |
3 |
0.0000 |
| 131 |
HYPERTENSION |
1 |
0.0000 |
| 132 |
WEIGHT DECREASED |
1 |
0.0000 |
| 133 |
DIARRHOEA |
2 |
0.0000 |
| 134 |
PNEUMONIA |
1 |
0.0000 |
| 135 |
DIZZINESS |
1 |
0.0000 |
| 136 |
HEADACHE |
1 |
0.0000 |
| 137 |
NAUSEA |
1 |
0.0000 |